Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mylan Places Big Bet On Antihypertensives: $4 Bil. Deal For King

Aug 02 2004

• By The Pink Sheet

Related Content

J&J Duragesic Pediatric Exclusivity Blocks Mylan Generic Until January

Jun 28 2004

King Altace Inventory Levels To Be Stabilized Through Wholesaler Agreements

Feb 23 2004

FDA Levothyroxine Generic Approvals Upheld In First Court Challenge

Jul 12 2004

Cardinal CFO Departs Amid SEC, U.S. Attorney Investigations

Aug 02 2004

King Names COO Markison Acting CEO; President Macione Steps Down

May 24 2004

Altace Will Gain 1,000 Wyeth Reps Through Copromotion Deal

Jun 26 2000

Mylan Nebivolol Hypertension Drug Patent Protection Expected Through 2015

Apr 16 2001

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window